Masood A. Shammas

The paper identifies an optimal cannabinoid-terpene ratio that reduces DCA-induced DNA damage and mutagenicity in esophageal cells and correlates ECS receptor expression with EAC progression.

This paper reviews and analyzes how multi-omics and AI/ML approaches integrate nutrition and metabolism in cancer, showing strong diagnostic and predictive capabilities and proposing a clinical algorithm for low-resource settings.

This study validates ZNF208 mutation (c.64G>A) as a specific biomarker for advanced phase CML through targeted resequencing in a case-control cohort.

This study identifies a FANCD2 mutation as a specific biomarker for early progression in Chronic Myeloid Leukemia using targeted resequencing and NGS analysis.